Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Total 13F shares
-
36,786,193
-
Share change
-
-2,377,344
-
Total reported value
-
$4,927,662,357
-
Put/Call ratio
-
66%
-
Price per share
-
$134.01
-
Number of holders
-
366
-
Value change
-
-$289,195,543
-
Number of buys
-
219
-
Number of sells
-
144
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q2 2025
As of 30 Jun 2025,
TransMedics Group, Inc. - Common Stock (TMDX) was held by
366 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,786,193 shares.
The largest 10 holders included
BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, FIL Ltd, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, MACQUARIE GROUP LTD, Driehaus Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
367
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.